Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Cash and Equivalents of $231.25 million for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $231.25M | +227.7% |
| 2024 | $70.56M | -70.5% |
| 2023 | $238.95M | +37.6% |
| 2022 | $173.69M | -6.8% |
| 2021 | $186.43M | +7.1% |
| 2020 | $174.12M | +2.4% |
| 2019 | $170.02M | +15.9% |
| 2018 | $146.63M | +23.5% |
| 2017 | $118.70M | -22.5% |
| 2016 | $153.22M | +60.1% |
| 2015 | $95.70M | +5756.6% |
| 2014 | $1.63M | -78.4% |
| 2013 | $7.55M | -36.7% |
| 2012 | $11.94M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $150.10M | +285.3% | +27.9% |
| June 30, 2025 | $117.35M | -32.1% | +22.0% |
| March 31, 2025 | $96.19M | -57.9% | +36.3% |
| December 31, 2024 | $70.56M | -70.5% | +81.1% |
| September 30, 2024 | $38.96M | -84.9% | -77.5% |
| June 30, 2024 | $172.89M | -39.1% | -24.4% |
| March 31, 2024 | $228.61M | -15.2% | -4.3% |
| December 31, 2023 | $238.95M | +37.6% | -7.6% |
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +227.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s cash and equivalents has grown by 1837.4% (from $11.94 million to $231.25 million).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: